Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABT

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter and narrowed fiscal 2025 guidance on Wednesday.

Benzinga

Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations

Abbott Laboratories (NYSE:ABT) stock fell after the company reported muted sales in the third quarter and narrowed fiscal 2025 guidance.

Benzinga

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories (NYSE:ABT) will release earnings results for the third quarter, before the opening bell on Wednesday, Oct. 15.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Dividend Kings For Generations Of Passive Income

These are five Dividend Kings, companies with 50+ years of dividend increases, covering recent developments, dividend safety, and valuation, so you can identify candidates for durable income that fit your goals.

Barchart

What to Expect From Abbott Laboratories' Next Quarterly Earnings Report

Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Barchart

How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks?

Although Abbott Laboratories has underperformed its industry peers recently, analysts remain highly optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Latino Dancer Isaac Hernández Dazzles New York in 'Swan Lake' Debut with American Ballet Theatre: Celebrated with Birria Tacos

Mexican-born ballet sensation Isaac Hernández made headlines this weekend in New York City, taking center stage at the Metropolitan Opera House as Prince Siegfried in Swan Lake. Performing as part of American Ballet Theatre's 2025 summer season,

Latin Times

What does one do on their last day as a ballerina? Gillian Murphy will jump off a cliff (gracefully)

After a career of nearly three decades, Gillian Murphy is hanging up her pointe shoes

The Independent UK

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.

Benzinga

Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year.

Benzinga

Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories (NYSE:ABT) will release earnings results for the second quarter, before the opening bell on Thursday, July 17.

Benzinga

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report

Abbott is poised to release its second-quarter results next month, and analysts project a single-digit earnings growth.

Barchart

Nurburgring 24 Hours: BMW wins after penalty for Porsche

Rowe BMW took Nurburgring 24 Hours victory after a penalty for the leading Manthey EMA Porsche following a clash, which meant that victory went to Raffaele Marciello, Kelvin van der Linde, Jesse Krohn and Augusto Farfus.

Motorsport

Get all your
news in one place.

100's of premium titles.
One news app.

Autosport

Nurburgring 24 Hours: BMW wins after post-race penalty for Porsche

The Independent UK

Misty Copeland broke barriers in ballet. Now she’s retiring and moving to ‘the next stage’

Trailblazing ballerina Misty Copeland has decided to move on to what she calls “the next stage” in her career

Barchart

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

Barchart

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

Autosport

How reigning DTM champion Mirko Bortolotti’s Abt switch is going

They were fierce title rivals last year, but Mirko Bortolotti has brought the coveted number one to the Abt DTM team for 2025, following title success last year.

Barchart

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

The Independent UK

From soup cans to airplanes, steel and aluminum are a fundamental part of American life

Steel and aluminum are ubiquitous in Americans’ lives

Barchart

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.